# Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia

> **NCT05512169** · — · RECRUITING · sponsor: **University of Geneva, Switzerland** · enrollment: 556 (estimated)

## Conditions studied

- ALL, Childhood
- Pediatric Cancer
- Toxicity, Drug
- Adverse Drug Event
- Relapse Leukemia
- Drug Toxicity
- Drug Effect
- Drug Interaction

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05512169
- **Lead sponsor:** University of Geneva, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-01
- **Primary completion:** 2027-03-30
- **Final completion:** 2027-03-30
- **Target enrollment:** 556 (ESTIMATED)
- **Last updated:** 2026-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05512169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05512169, "Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05512169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*